Oncoinvent is a drug development company based in Oslo, Norway. Oncoinvent develops novel alpha-emitting radioactive cancer treatments. Oncoinvents lead product Radspherin is currently undergoing clinical testing for the treatment of peritoneal carcinomatosis, a common metastatic complication of colorectal and ovarian cancer.
YEAR OF INVESTMENT
2020
SECTOR
Drug development
LOCATION
Oslo, Norway
WEBSITE
https://www.oncoinvent.com/